Home > PS Ratio > AJANTA PHARMA

AJANTA PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of AJANTA PHARMA is 6.66.

Share Price ₹2,135.8Apr 23,2024
Market Cap ₹26,889.7 Cr
Sales-TTM₹4,036.5 CrTTM-Consolidated Results
Price/Sales6.66xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AJANTA PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AJANTA PHARMA is calculated as :

Current Market Cap [ ₹26,889.7 Cr] as on Apr 23,2024

(/) Sales [ ₹4,036.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 6.66x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AJANTA PHARMA , the investors are currently willing to pay '6.66 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AJANTA PHARMA !

The chart below summarizes the trend in P/S Ratio of AJANTA PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of AJANTA PHARMA


PS Ratio Performance Analysis for AJANTA PHARMA

- AJANTA PHARMA 's latest p/e ratio is 6.66x.

- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.61x.

- AJANTA PHARMA 's operated at median p/e ratio of 4.61x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2021 at 5.37x.

- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2023 of 4.07x.


How does AJANTA PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AJANTA PHARMA 4,036.56.6626,889.7
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.50356,001.0
CIPLA LTD25,350.24.29108,813.0
DR REDDYS LABORATORIES LTD27,212.53.6599,325.3
ZYDUS LIFESCIENCES LTD19,024.25.0896,553.2
DIVIS LABORATORIES LTD7,492.813.36100,075.0
MANKIND PHARMA LTD9,946.39.6495,896.9
TORRENT PHARMACEUTICALS LTD10,474.08.5289,224.4
LUPIN LTD19,480.13.7072,033.6
AUROBINDO PHARMA LTD27,894.72.3064,043.1
ABBOTT INDIA LTD5,753.49.5154,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AJANTA PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.30x
Max industry PS 13.36x
Median industry PS 6.66x
Average industry PS 6.75x



You may also like the below Video Courses